UBS AM’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,111,231
Closed -$129M 2641
2023
Q3
$129M Buy
1,111,231
+83,525
+8% +$9.66M 0.06% 348
2023
Q2
$112M Hold
1,027,706
0.05% 363
2023
Q1
$112M Buy
1,027,706
+20,476
+2% +$2.23M 0.05% 363
2022
Q4
$115M Buy
1,007,230
+22,248
+2% +$2.53M 0.06% 352
2022
Q3
$61M Buy
+984,982
New +$61M 0.03% 487
2019
Q2
Sell
-131,561
Closed -$3.48M 2910
2019
Q1
$3.48M Buy
131,561
+8,386
+7% +$222K ﹤0.01% 1283
2018
Q4
$2.41M Buy
123,175
+15,227
+14% +$298K ﹤0.01% 1362
2018
Q3
$2.11M Buy
107,948
+3,182
+3% +$62.3K ﹤0.01% 1482
2018
Q2
$1.73M Sell
104,766
-9,952
-9% -$165K ﹤0.01% 1570
2018
Q1
$1.63M Buy
114,718
+10,694
+10% +$152K ﹤0.01% 1561
2017
Q4
$1.52M Buy
104,024
+10,780
+12% +$157K ﹤0.01% 1554
2017
Q3
$1.18M Buy
93,244
+5,104
+6% +$64.7K ﹤0.01% 1635
2017
Q2
$1.05M Sell
88,140
-91,238
-51% -$1.08M ﹤0.01% 1639
2017
Q1
$2.65M Sell
179,378
-65,155
-27% -$963K ﹤0.01% 1233
2016
Q4
$3.96M Sell
244,533
-461,399
-65% -$7.46M ﹤0.01% 1047
2016
Q3
$12.8M Sell
705,932
-13,252
-2% -$240K 0.01% 823
2016
Q2
$11.8M Buy
719,184
+231,170
+47% +$3.81M 0.01% 839
2016
Q1
$8.09M Buy
488,014
+388,001
+388% +$6.43M 0.01% 895
2015
Q4
$2.17M Buy
100,013
+17,173
+21% +$372K ﹤0.01% 1407
2015
Q3
$1.64M Buy
82,840
+7,256
+10% +$144K ﹤0.01% 1515
2015
Q2
$2.63M Buy
75,584
+27,184
+56% +$944K ﹤0.01% 1280
2015
Q1
$1.26M Buy
48,400
+13,600
+39% +$353K ﹤0.01% 1546
2014
Q4
$449K Buy
34,800
+5,200
+18% +$67.1K ﹤0.01% 2002
2014
Q3
$363K Buy
29,600
+16,100
+119% +$197K ﹤0.01% 2036
2014
Q2
$214K Buy
+13,500
New +$214K ﹤0.01% 2379